5y outlook: Entry-level outpatient clinical pay with limited upward salary movement unless the MA pursues additional certifications, lead MA roles, or further clinical education.
Job intelligence board
Loading scored roles…
Optum/UHG
5y outlook: Stable salary outlook with incremental increases based on experience and productivity; home health OTA roles are in steady demand but compensation growth is modest.
5y outlook: Home health occupational therapy demand is likely to remain stable due to aging populations and home-based care expansion, but this part-time role will likely be paid hourly or per visit and prorated from the posted full-time salary range.
Optum/UHG
5y outlook: Base range posted is roughly $99k–$148k plus incentive compensation; earnings tied to census and referral growth, so total pay varies with market performance. Advancement typically runs toward regional sales director or agency/operations leadership.
Optum/UHG
5y outlook: Likely stable outpatient primary care demand, but LPN pay progression is generally limited without additional licensure, specialization, or leadership responsibilities; confirm local market pay.
Optum/UHG
5y outlook: LPN ambulatory roles in large health systems typically offer stable hourly pay with modest annual increases; upside usually comes from specialization, care-management pathways, or pursuing RN licensure rather than from this title itself.
5y outlook: Stable administrative revenue cycle role with modest salary growth; advancement typically requires additional coding certifications or supervisory experience. Exact salary depends on location and experience.
5y outlook: Likely structured as base salary plus variable incentive tied to retention and growth; earnings can increase with PBM/account management experience, but exact compensation depends on portfolio, quota, and geography. This is not an entry-level non-clinical transition role.
Optum/UHG
5y outlook: The posting lists a base salary range of $62,320 to $93,480 with incentives and benefits. Over five years, total earnings will depend more on territory performance, quota attainment, and sales management progression than on clinical tenure.
Optum/UHG
5y outlook: The posting lists an hourly range of $44-$79, but per diem hours may be irregular and benefits eligibility can vary. Long-term earnings depend on coverage volume, location needs, and progression into full-time or specialized pharmacy roles.
Optum/UHG
5y outlook: Stable demand in multi-specialty group practices and value-based care settings, but compensation growth is typically modest unless moving into lead MA, clinical operations, or care coordination roles.
5y outlook: Likely a stable senior individual-contributor accounting path within a large healthcare organization. Compensation is not disclosed and will depend on market, credentials, and PBM/healthcare finance experience.
Optum/UHG
5y outlook: The posting lists an hourly range with benefits, but long-term pay growth in this type of CNA/LNA hospice aide role is likely modest unless the clinician adds credentials or moves into supervisory, care coordination, or clinical operations roles.
AstraZeneca
5y outlook: Likely a solid pharma analytics/BI career track with compensation above general reporting roles, though exact pay depends on location, seniority, and rare-disease commercial analytics experience. Clinicians without prior BI/data engineering experience should expect a retraining period before competitive for this level.
AstraZeneca
5y outlook: Senior AI/ML leadership roles in large pharma tend to command premium compensation, with exact pay dependent on location, level, and total rewards structure. Five-year outlook is strong for leaders with production GenAI and agentic AI experience, though expectations will rise as the field matures.
5y outlook: Likely a competitive pharma medical affairs/launch role with salary growth tied to oncology launch experience, strategic scope, and cross-functional leadership. Exact compensation is not stated and should be verified directly.
5y outlook: Likely competitive senior pharma commercial analytics compensation, with progression toward franchise, insights, or commercial strategy leadership. Exact salary depends on location and internal band and is not disclosed.
5y outlook: Experienced HEOR and market access professionals generally have strong pharma compensation prospects, but this is a short fixed-term/secondment role with no guaranteed permanent conversion. Long-term value depends on using the HTA modelling and submission experience to move into permanent HEOR or market access roles.
5y outlook: Likely structured as base salary plus variable sales incentive; earnings can grow with territory performance and progression into sales management or medical affairs, but exact pay depends on local market and quota attainment.
AstraZeneca
5y outlook: Senior pharma statistical programming roles typically offer competitive compensation and stable demand, with progression toward lead/principal programmer or biometrics leadership. Exact salary varies by location, experience, and company.
NHS Jobs
5y outlook: Salary is not stated; NHS clinical governance leadership roles generally align with Agenda for Change management or clinical leadership bands, with progression depending on band, NHS experience, and whether the post carries a clinical mandate.
NHS Jobs
5y outlook: Likely paid on NHS Agenda for Change banding typical of specialist midwife/governance posts, with modest progression unless moving into senior patient safety or maternity governance leadership.
5y outlook: NHS Band 8A is a senior managerial/lead grade with stable incremental progression, but exact pay depends on NHS scales and location. Five-year growth is steady; progression would likely require moving into Band 8B/8C operational leadership or specialist improvement roles.
NHS Jobs
5y outlook: Likely aligned with NHS administrative or governance support pay bands, with progression dependent on gaining quality improvement, audit, and patient safety experience. Exact salary is unclear from the posting.